MRNA vs ONC
Moderna and BeOne Medicines AG, both Healthcare
BeOne Medicines AG is the larger company at $29B against $25B. Over the past year MRNA returned +93% against +5.9% for ONC.
| Figure | MRNA | ONC |
|---|---|---|
| Last close | $62.96 | $354 |
| Market cap | $25B | $29B |
| 1-year return | +93% | +5.9% |
| 5-year return | -81% | -4.0% |
| RyuScoresector-relative, 1–10 | 48/100 | n/a |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Moderna
Revenue of $145M in Q2 2026, net income null. Its largest reported line is COVID19, 63% of the disclosed total.
BeOne Medicines AG
Open these two in the interactive comparison to add more names, change the period or see the correlation.